ELCC 2016: Exhibitor Profiles

Pharmaceutical Companies

Abbvie

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories.  AbbVie is a leading company with the stability, resources, expertise and passion to discover, develop and bring to market groundbreaking science to solve the biggest health problems that face the world today and tomorrow. AbbVie employs approximately 25,000 people worldwide and markets medicines in 170+ countries.
www.abbvie.com.
Booth Number: 12

ARIAD Pharmaceuticals (Europe) Sàrl

ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and Lausanne, Switzerland, is an integrated global oncology company focused on transforming the lives of cancer patients with breakthrough medicines. ARIAD is working on new medicines to advance the treatment of various forms of chronic and acute leukemia, lung cancer and other difficult-to-treat cancers. ARIAD utilizes computational and structural approaches to design small-molecule drugs that overcome resistance to existing cancer medicines.
www.ariad.com.
Booth Number: 28

AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
www.astrazeneca.com
Booth Number: 14

Boehringer Ingelheim

Boehringer Ingelheim is committed to delivering novel anti-cancer agents that address unmet needs across a broad range of solid and haematological malignancies. For lung cancer BI now has two agents approved in a number of markets for specific NSCLC sub-types. The late stage portfolio is supported by a strong early pipeline and was recently supplemented with a major in-licensing deal of a novel therapeutic vaccine.
www.inoncology.com
Booth Number: 13

Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Our medicines are helping millions of people around the world in their fight against cancer, cardiovascular disease, hepatitis C, HIV and rheumatoid arthritis.
www.bms.com
Booth Number: 3

Clovis Oncology

We are a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our development programs target specific subsets of cancer populations, combining personalized medicine with companion diagnostics to direct therapeutics to those patients most likely to benefit from their use.
clovisoncology.com
Booth Number: 20

F. Hoffmann-La Roche Ltd

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-four medicines developed by Roche are included in the WHO Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy.

In 2014, the Roche Group employed 88,500 people worldwide, invested 8.9 billion Swiss francs in R&D and posted sales of 47.5 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit the company website
roche.com
Booth Number: 30

Lilly Oncology

For more than 50 years, Lilly has been dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. Lilly is determined to build on this heritage and continue making life better for all those affected by cancer around the world. To learn more about Lilly’s commitment to people with cancer, please visit the company website.
www.LillyOncology.com
Booth Number: 2

MSD

Today's MSD is a global health care leader working to help the world be well. MSD is a tradename of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. For more information, visit the company website.
www.msd.ch
Booth Number: 29

Novartis Oncology

Novartis Oncology is a global leader in improving outcomes for patients. We seek to transform cancer care through distinctive scientific and clinical strategies focused on developing targeted, immuno-oncology and combination therapies to create more effective options for patients. For more information, please visit the company website.
www.novartisoncology.com
Booth Number: 9

Otsuka Pharmaceutical Europe

Otsuka is a global healthcare company with the corporate philosophy: 'Otsuka-people creating new products for better health worldwide.' Otsuka is committed to focusing its research and development on innovative products and medical devices that address unmet medical needs. Come and visit Otsuka Europe at Stand 143 to learn more about Otsuka’s commitment to innovation and education.
www.otsuka-europe.com
Booth Number: 25

Pfizer Oncology

Pfizer Oncology is committed to the research and discovery of breakthrough treatment options, including small molecules, biologics and immunotherapies, to improve the outlook for cancer patients worldwide. For more information please visit the company website.
www.pfizer.com
Booth Number: 10

Pfizer/Merck Alliance

Pfizer Merck Horiz Logo

Immuno-oncology is a top priority for Merck and Pfizer. The global strategic alliance between Merck and Pfizer enables the companies to benefit from each other’s strengths and capabilities and further explore the therapeutic potential of avelumab, an investigational anti-PD-L1 antibody initially discovered and developed by Merck. The immuno-oncology alliance will jointly develop and commercialize avelumab and advance Pfizer’s PD-1 antibody.
Booth Number: 11

Roche Sequencing

We are focused on developing novel sequencing technologies and products to support innovation in clinical research applications. Our teams are developing assays for sequencing, and refining techniques to advance sequencing technologies that will deliver truly differentiated clinical value.
sequencing.roche.com
Booth Number: 31

Societies

European Society for Medical Oncology

ESMO is the leading professional organisation for medical oncology. Comprising more than 13,000 oncology professionals from over 130 countries, we are the society of reference for oncology education and information. We are committed to supporting our members to develop and advance in a fast-evolving professional environment.
Founded in 1975, ESMO has European roots and a global reach: we welcome oncology professionals from around the world. We are a home for all oncology stakeholders, connecting professionals with diverse expertise and experience. Our educational and information resources support an integrated, multi-professional approach to cancer treatment. We seek to erase boundaries in cancer care as we pursue our mission across oncology, worldwide.
Booth Number: 4

American Society of Clinical Oncology (ASCO)

The American Society of Clinical Oncology (ASCO) strives to conquer cancer through research, education, and promotion of the highest quality patient care. ASCO’s diverse membership includes every oncology specialty and professionals from nearly 150 countries, representing the world’s largest professional oncology organization. We will be exhibiting at the Conference and available to answer questions about ASCO and ASCO membership!
www.asco.org
Booth Number: 27

European SocieTy for Radiotherapy and Oncology (ESTRO)

ESTRO is a non-for-profit organisation that advances all aspects of radiation oncology in order to improve patient’s care in the multimodality treatment of cancer.
With 6,500 members around the world, ESTRO’s mission is to promote education, science dissemination and access to radiotherapy, hence supporting all the radiation oncology professionals in their daily practice.
www.estro.org
Booth Number: 7

European Thoracic Oncology Platform

ETOP is a not-for-profit organization promoting academic clinical research and the exchange of ideas in the field of thoracic oncology. It sponsors and manages an increasing number of translational research projects and clinical trials with an emphasis on advancing the knowledge in thoracic malignancies. ETOP comprises more than 50 collaborative groups and institutions from all over Europe and beyond.
The specific aims of ETOP are:
To serve as a meeting platform for European study groups and institutions engaged in research on thoracic malignancies
To foster intergroup studies among study groups and institutions across Europe and beyond
To sponsor and/or perform own studies
To foster scientific exchange on clinical and translational research among interested parties and beyond
To provide knowledge to partners in the field
www.etop-eu.org

International Association for the Study of Lung Cancer (IASLC)

The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated to the study of lung cancer.
Founded in 1974, the association's membership includes nearly 4,000 lung cancer specialists in 80 countries.
IASLC members work to enhance the understanding of lung cancer among scientists, members of the medical community and the public. IASLC publishes the Journal of Thoracic Oncology, a valuable resource for medical specialists and scientists who focus on the detection, prevention, diagnosis and treatment of lung cancer.
www.iaslc.org
Booth Number: 5

Publisher/Bookseller

Wisepress Medical Bookshop

Wisepress.com, Europe’s leading conference bookseller, has a range of books and journals relevant to the themes of the meeting. In addition to attending 200 conferences per year, Wisepress has a comprehensive medical and scientific bookshop online with great offers. Follow us on Twitter for the latest news @WisepressBook
www.wisepress.com
Booth Number: 40